Nutraceutical Excipients Market Will Hit Big Revenues In Future

Northbrook, USA, 2020-Sep-23 — /EPR Network/ —The Report ” Nutraceutical Excipients Market by Functionality (Binders, Fillers & Diluents, Coating Agents, and Flavoring Agents), End Product (Prebiotics, Probiotics, Proteins & Amino Acids, and Vitamins), Form (Dry and Liquid), and Region – Global Forecast to 2025“, The global nutraceutical excipients market size is estimated to account for about USD 3.4 billion in 2020 and projected to reach a value of nearly USD 4.9 billion by 2025, growing at a CAGR of 7.3% from 2020 to 2025. The market for nutraceutical excipients market has been growing in accordance with the rise in demand and consumption for nutraceuticals, around the globe. The consumption of dietary supplements in the form of tablets and capsules has been witnessing an upsurge demand in recent times, owing to the growing awareness for health benefits offered by these products that helps to support the wellbeing of the consumers. The key driving factors of the nutraceutical excipients market include increasing consumer concerns regarding maintaining a balanced diet and growing consumer awareness about several diseases caused due to lack of intake of necessary nutrients as a result of imbalanced dietary lifestyles. Food fortification is one of the major trends, which is also fueling the nutraceutical excipients market in the functional food & beverage industry.

Driver: Advancements in nanotechnology equipped with new features to drive the growth of the market

Nanotechnology-enabled drug delivery systems (NDDS) are used to cater to the issue of drug toxicity. There are two major approaches to use nanotechnology as a drug delivery system (DDS). The first is to reduce the size of nutraceutical drug crystals to ensure enhanced solubility and bioavailability, while the second approach is to use some form of nano-carrier for effective delivery of active ingredients. In March 2009, the scientific committee of the European Food Safety Agency published an opinion on nanoscience and nanotechnology regarding food and feed safety. A document offering guidance on how to assess potential risks associated with certain food-related uses of nanotechnology was followed in May 2011, providing practical recommendations to regulators on how to assess applications that use engineered nanomaterials in food additives, enzymes, flavorings, food contact materials, novel foods, food supplements, feed additives, and pesticides.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247060367

Poor drug physicochemical properties can be improved by associating the drug with a pharmaceutical carrier. A drug delivery system (DDS) can enhance a drug’s pharmacokinetics and cellular penetration. Moreover, the drug delivery system (DDS) may also address obstacles arising from low drug solubility, degradation, fast clearance rates, nonspecific toxicity, and inability to cross biological barriers. Hence, the use of nanotechnology for improving the functionalities of excipients is also projected to drive the growth of the nutraceutical excipients market during the forecast period.

Opportunity: High use of excipients with multifunctional properties is witnessed as an emerging trend among key players.

Multifunctional excipients are a class of excipients that include pre-processed and co-processed excipients that provide added functionalities to the formulation. For example, Silicified Micro-Crystalline Cellulose is a processed combination of MCC and colloidal silicon dioxide. These functionalities include flowability, compressibility, particle size distribution, shape, and porosity. The term multifunctional excipient is also extended to products that serve multiple roles in the formulation of dietary supplement and functional food & beverage line of products; for example, Ludipress is a co-processed product containing lactose, Kollidon, and Kollidon-CL, which serves the role of DC diluent with binder and disintegrant properties.

The demand for excipients with improved functionalities in the nutraceutical industry remains high, while also minimizing the drawbacks of incorporated excipients. According to the International Pharmaceutical Excipient Council (IPEC), a co-processed excipient is “a combination of two or more compendial or non-compendial excipients designed to physically modify their properties in a manner not achievable by simple physical mixing, and without significant chemical change.”

North America is estimated to dominate the nutraceutical excipients market in 2020

North America accounted for the largest market share in 2019. The nutraceutical excipients market in North America is dominating, owing to the concentration of the global players such as DuPont (US), Kerry (Ireland), Cargill (US), and Ingredion (US). The market for nutraceutical excipients here is mature, and hence, the growth is moderate compared to other regions. Other factors contributing to the growth of nutraceutical excipients in North American region include the busy lifestyle of consumers, prevalence of chronic diseases due to hectic lifestyles, and an increase in awareness among consumers regarding the health benefits of nutritional foods, including food supplements, which has driven the demand for functional food products. In addition, the use of technological advancements and new product launches have made excipients available for a wide range of applications in the fortified food & beverage, dietary supplements, and nutraceuticals sectors, which is projected to drive the growth of the market in the region.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=247060367

This report includes a study of marketing and development strategies, along with the product portfolios of the leading companies in the nutraceutical excipients market.  The key players in the nutraceutical excipients market include DuPont (US), BASF SE (Germany), Kerry Group PLC (Ireland), Ingredion Plc (US), Sensient Technologies (US), Associated British Foods (UK), Roquette Freres (France), Meggle Group Wasser (Germany), Cargill Inc (US), Ashland Global Holdings Inc (US), Seppic (France), Shin-Etsu Chemical Co Ltd (Japan), Fuji Chemical Industries Co Ltd (Japan), Pharmatrans Sanaq AG (Switzerland), Pioma Chemicals (India), Gattefosse (India), W.R.Grace & Co (US), Omya (Switzerland), Grain Processing Corp (US), and Gangwal Chemicals Pvt Ltd (India). The nutraceutical excipients market also consists of key start-up players, which include IMCD (Netherlands), Hilmar Ingredients (US), Innophos Holdings Inc (US), JRS Pharma (Germany), Biogrund GmbH (Germany), Pharma Line Intl Corp (South Korea), Jigs Chemical (India), Panchamrut Chemicals (India), Azelis Chemical Ltd (Europe), and Daicel Group (Japan).

Recent Developments:

• In June 2020, IMCD announces the extension of its partnership with DuPont Health and nutrition (US). This development will benefit both the companies in strengthening their footprints in Kenya, Uganda, and Egypt by offering a combined line of products to distinct industry users.
• In March 2020, Azelis Chemical Ltd signed an agreement with CosBond (China), a specialty chemical and food ingredient distributor, to acquire it. This development helped Azelis strengthen its distribution network in the Chinese market with the expertise of CosBond’s existing network channel and reach.
• In December 2019, DuPont signed an agreement to merge its Nutrition & Biosciences business with IFF (US). The development details include valuing the combined company at USD 45.4 Billion. DuPont owned a majority of the shares, which is 55.4% and the remaining 44.6% by IFF, which is unanimously approved. This development is expected to help the company broaden its capabilities offering nutritional ingredients and solutions to global consumers.